Search

Displaying results 9621 - 9630 of 10000 in total
  1. Drug

    VH3739937

    go.drugbank.com/drugs/DB25287
    Investigational

    is under investigation in clinical trial NCT06533280 (VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and

  2. Drug

    Tanogitran

    go.drugbank.com/drugs/DB21367
    Investigational

    Tanogitran is under investigation in clinical trial NCT02254057 (Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects).

  3. Drug

    Masofaniten

    go.drugbank.com/drugs/DB21580
    Investigational

    Masofaniten is under investigation in clinical trial NCT06312670 (Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer).

  4. Drug

    TA-CIN

    go.drugbank.com/drugs/DB05809
    Investigational

    TA-CIN is a subunit vaccine comprising L2/E6/E7 proteins from Human Papillomavirus (HPV16), designed to generate a strong cellular immune response against HPV-infected cells.

  5. Drug

    Biphenylol

    go.drugbank.com/drugs/DB13734
    Investigational

    Categories: Phenol and Derivatives, Antiseptics and Disinfectants
  6. Drug

    FT-1101

    go.drugbank.com/drugs/DB17553
    Investigational

    FT-1101 is a novel Bromodomain and Extra-Terminal motif (BET) inhibitor.

  7. Drug

    Demoxytocin

    go.drugbank.com/drugs/DB13798
    Experimental

    Categories: Pituitary and Hypothalamic Hormones and Analogues, Oxytocin and Analogues
  8. Drug

    Isopropyl beta-D-thiogalactopyranoside

    go.drugbank.com/drugs/DB01862
    Experimental

    A non-metabolizable galactose analog that induces expression of the LAC operon.

  9. Drug

    NM-3

    go.drugbank.com/drugs/DB12818
    Investigational

    NM-3 has been used in trials studying the treatment of Neoplasms.

    Synonyms: NM-3
  10. Drug

    Bucainide

    go.drugbank.com/drugs/DB20650
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Bucainide is a class I antiarrhythmic, procainamide and lidocaine derivative. Bucainide has a monoisotopic molecular weight of 329.28 Da.